ACHC vs. ENSG, INSP, ELAN, XRAY, PCVX, JAZZ, APLS, HQY, EXEL, and GMED
Should you be buying Acadia Healthcare stock or one of its competitors? The main competitors of Acadia Healthcare include The Ensign Group (ENSG), Inspire Medical Systems (INSP), Elanco Animal Health (ELAN), DENTSPLY SIRONA (XRAY), Vaxcyte (PCVX), Jazz Pharmaceuticals (JAZZ), Apellis Pharmaceuticals (APLS), HealthEquity (HQY), Exelixis (EXEL), and Globus Medical (GMED). These companies are all part of the "medical" sector.
The Ensign Group (NASDAQ:ENSG) and Acadia Healthcare (NASDAQ:ACHC) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, community ranking, analyst recommendations, institutional ownership and media sentiment.
96.1% of The Ensign Group shares are held by institutional investors. 3.9% of The Ensign Group shares are held by company insiders. Comparatively, 2.8% of Acadia Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
In the previous week, The Ensign Group had 1 more articles in the media than Acadia Healthcare. MarketBeat recorded 7 mentions for The Ensign Group and 6 mentions for Acadia Healthcare. The Ensign Group's average media sentiment score of 0.56 beat Acadia Healthcare's score of 0.44 indicating that Acadia Healthcare is being referred to more favorably in the news media.
The Ensign Group currently has a consensus price target of $123.60, suggesting a potential upside of 4.18%. Acadia Healthcare has a consensus price target of $94.75, suggesting a potential upside of 33.09%. Given The Ensign Group's higher possible upside, analysts plainly believe Acadia Healthcare is more favorable than The Ensign Group.
Acadia Healthcare received 202 more outperform votes than The Ensign Group when rated by MarketBeat users. Likewise, 66.91% of users gave Acadia Healthcare an outperform vote while only 66.04% of users gave The Ensign Group an outperform vote.
The Ensign Group has higher revenue and earnings than Acadia Healthcare. Acadia Healthcare is trading at a lower price-to-earnings ratio than The Ensign Group, indicating that it is currently the more affordable of the two stocks.
The Ensign Group has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, Acadia Healthcare has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500.
The Ensign Group has a net margin of 5.61% compared to The Ensign Group's net margin of -0.74%. Acadia Healthcare's return on equity of 17.84% beat The Ensign Group's return on equity.
Summary
The Ensign Group beats Acadia Healthcare on 11 of the 18 factors compared between the two stocks.
Get Acadia Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ACHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Acadia Healthcare Competitors List
Related Companies and Tools
